506 related articles for article (PubMed ID: 1382289)
1. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.
Richter W; Eiermann TH; Endl J; Seissler J; Wolfahrt S; Brandt M; Jungfer H; Scherbaum WA
Diabetologia; 1993 Aug; 36(8):785-90. PubMed ID: 7691667
[TBL] [Abstract][Full Text] [Related]
3. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
Richter W; Seissler J; Northemann W; Wolfahrt S; Meinck HM; Scherbaum WA
Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
[TBL] [Abstract][Full Text] [Related]
5. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.
Richter W; Shi Y; Baekkeskov S
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2832-6. PubMed ID: 7681990
[TBL] [Abstract][Full Text] [Related]
7. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
DeAizpurua HJ; Honeyman MC; Harrison LC
J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal autoantibodies from insulin-dependent diabetic patients: autoantibodies against beta-cell surface or cytoplasmic antigens.
Houssaint E; Pogu S; Ouary M; Sai P
Clin Exp Immunol; 1990 Oct; 82(1):44-51. PubMed ID: 1698582
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
[TBL] [Abstract][Full Text] [Related]
10. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.
Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA
Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232
[TBL] [Abstract][Full Text] [Related]
12. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
13. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
[TBL] [Abstract][Full Text] [Related]
14. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase 65 and are somatically mutated.
Madec AM; Rousset F; Ho S; Robert F; Thivolet C; Orgiazzi J; Lebecque S
J Immunol; 1996 May; 156(9):3541-9. PubMed ID: 8617984
[TBL] [Abstract][Full Text] [Related]
15. Transfer of type 1 (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID).
Petersen JS; Marshall MO; Baekkeskov S; Hejnaes KR; Høier-Madsen M; Dyrberg T
Diabetologia; 1993 Jun; 36(6):510-5. PubMed ID: 8335172
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
[TBL] [Abstract][Full Text] [Related]
17. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.
Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL
J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989
[TBL] [Abstract][Full Text] [Related]
18. Binding of antibodies in sera from Type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme.
Christie MR; Brown TJ; Cassidy D
Diabetologia; 1992 Apr; 35(4):380-4. PubMed ID: 1516767
[TBL] [Abstract][Full Text] [Related]
19. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
